Clinical trial
Follow-up Study in French Practice to Evaluate the Improvement of Gait and Pain Relief in Patients Treated With Endovascular Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon
NCT04798352 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Follow-up Study in French Practice to Evaluate the Improvement of Gait and Pain Relief in Patients Treated With Endovascular Endovascular Treatment of de Novo Lesions of the Femoropopliteal Artery Above the Knee With LUTONIX®035 or RANGER TM Active Ballon
- Lead sponsor
- Centre Hospitalier Universitaire Dijon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 4, 2020
- Completion date
- January 8, 2026
- Enrollment
- 293 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug-coated balloon catheter